目的: 分析维持性血液透析门诊费用影响因素,为开展门诊医保支付方式改革提供参考。方法: 基于福建省某市1797名血液透析患者在定点医疗机构的透析费用相关数据,构建多元线性回归模型。结果: 影响月均门诊费用的自变量标准化系数由高到低依次为透析次数、是否为独立透析中心、血液透析次数占比、参保人员身份、合并症类别、是否住院、是否终止透析、透析龄,回归模型R2=0.5542,F=241.85,p=0.000;56.52%的透析机构月均门诊费用模型预测数据与实际结算数据相差在±3%范围内。结论: 维持性血液透析门诊费用具备医保打包支付条件,建议以签约透析机构为打包支付对象,以月均门诊费用为打包支付单元,结合透析次数形成参数化的医保支付标准。同时,进一步系统化研究按透析质量付费的结算细则、考评体系、激励约束机制。
Abstract
Objective: The paper analyzes the influencing factors of outpatient expenses for maintenance hemodialysis and provides a reference for the reform of outpatient medical insurance payment methods. Methods: Based on the medical cost data of 1797 hemodialysis patients receiving dialysis treatment at designated medical institutions in a city of Fujian Province, a multiple linear regression model was constructed. Results: The standardized coefficients of the independent variables that affect the monthly average outpatient expenses, from high to low, is dialysis frequency, whether it is an independent dialysis center, ratio of hemodialysis frequency to total dialysis frequency, insured person's identity, category of comorbidity, whether the patients are hospitalized, whether the dialysis terminate, and years of dialysis. The regression model R2=0.5542, F=241.85, p=0.000. 56.52% of dialysis institutions have a difference range of ± 3% between the predicted monthly outpatient cost model data and the actual settlement data. Conclusion: The outpatient expenses for maintenance hemodialysis meet the conditions for medical insurance packaging payment. It is recommended to select designated dialysis institutions as the targets for medical insurance packaging payment, and monthly average outpatient expenses as the unit of packaging payment, and form a parameterized medical insurance payment standard based on the dialysis frequency. At the same time, further systematic research could be conducted on the settlement rules, evaluation system, and incentive-constraint mechanisms for payment based on dialysis quality.
关键词
血液透析 /
门诊费用 /
影响因素 /
医保支付方式改革 /
按病种付费
Key words
hemodialysis /
outpatient expenses /
influencing factors /
reform of medical insurance payment methods /
pay by disease
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 许永建.浙江省某市终末期肾病单病种付费实施现况及对策研究[D].杭州:杭州师范大学,2012.
[2] 许永建,任建萍,卫萍,等.终末期肾病单病种付费实施现况及个人支付费用影响因素研究[J].医学与哲学(B),2014,35(02):95-97.
[3] 邹志辉,吴洋,陈继芳,等.广州市三级综合医院终末期肾病医保患者透析治疗的成本-效用评价[J].广州医科大学学报,2019,47(06):122-124.
[4] 李晓娜,顾锦旭,吴萍,等.南通市2015—2018年终末期肾病单病种付费实施现状研究[J].江苏卫生事业管理,2019,30(09):1138-1140.
[5] 马颖慧,周子君.血液透析相关医疗费用综述[J].中国血液净化,2016,15(04):244-246.
[6] 潘园园.福建省本级参保尿毒症患者每周可免费血透两次[EB/OL].(2015-07-05)[2023-09-20].http://fjnews.fjsen.com/2015-07/05/content_16319055.htm.
[7] 福州市医疗保障基金管理中心.关于规范开展基本医疗保险优惠救治工作的通知:榕医保文〔2017〕85号[EB/OL].(2018-02-07)[2023-09-20].http://www.fuzhou.gov.cn/zgfzzt/ylws/ybzchb/201802/t20180207_2011309.htm.
[8] 张育安,杨玉琼,周盛,等.组合式透析与单纯透析对血液透析患者并发症及死亡率的影响[J].中国中西医结合肾病杂志,2021,22(01):66-68.
[9] 刘敬,曹杰,萧倩筠.广州某医院医保病人血液透析费用的影响因素分析[J].现代医院,2016,16(09):1367-1368+1371.
[10] 叶可平.MHD患者中华生存质量与透析充分性的关系研究[D].北京:中国中医科学院,2020.
[11] 廖藏宜.后DRG时代门诊医保付费方式的改革趋势[J].中国人力资源社会保障,2021(04):59.
[12] 沈伟彬,文光慧.肾透析按人头付费医保门诊特殊病支付标准的研究[J].中国卫生标准管理,2018,9(15):18-20.
[13] 天津市医疗保障局,天津市卫生健康委.关于全面推行糖尿病门诊特定疾病按人头总额付费有关工作的通知:津医保局发〔2021〕115号[EB/OL].(2022-02-16)[2023-09-20].https://ylbz.tj.gov.cn/xxgk/zcfg/ybjwj/202202/t20220216_5805343.html.
[14] 刘双.定点医院尿毒症透析结算办法思考[J].中国管理信息化,2019,22(11):99-100.
[15] 浙江省医疗保障局.关于印发《浙江省全面推进医保支付方式改革三年行动计划》的通知:浙医保发〔2022〕14号[EB/OL].(2022-03-31)[2023-09-20].http://ybj.zj.gov.cn/art/2022/3/31/art_1229225623_2399422.html.
[16] 朱玄,杨金凤,王萍.美国终末期肾病质量激励计划的实施经验与启示[J].中国卫生经济,2023,42(06):93-96.
基金
福建省社科研究基地重大项目“保险视角下防范因病致贫返贫风险的长效机制研究”(FJ2022MJDZ040); 福建省社会保险人力资源研究会2021年度委托课题“维持性血液透析患者医疗费用影响因素分析与医疗保障政策优化”